Too Few U.S. Young Adults Being Prescribed Needed Statins

Share this content:
Too Few U.S. Young Adults Being Prescribed Needed Statins
Too Few U.S. Young Adults Being Prescribed Needed Statins

WEDNESDAY, Jan. 4, 2017 (HealthDay News) -- Too few American young adults are receiving needed statin medications, according to findings published online Jan. 4 in JAMA Cardiology.

David Zidar, M.D., Ph.D., of the University Hospitals Cleveland Medical Center, and colleagues tracked rates of statin prescriptions in people screened for dyslipidemia. The team examined data on inpatient and outpatient visits that occurred over a three-year period at 360 medical centers across the country. All patients were between the ages of 20 and 75.

Overall, 2,884,260 individuals were included in the study. The researchers found that 3.8 percent of them had a low-density lipoprotein (LDL) cholesterol level that met or exceeded the 190 mg/dL threshold for statin use. However, 34 percent of patients with severe dyslipidemia (but without any diagnosis of cardiovascular disease or diabetes) didn't get a statin. In addition, 25 percent of patients with even more severe LDL levels (greater than 250 mg/dL) weren't prescribed a statin. The younger the patient, the less likely they were to get a statin. For example, when needed, the drugs were only prescribed for 32 percent of patients in their 30s, 47 percent of those in their 40s, and 61 percent of patients in their 50s.

"Treatment with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors or statins is recommended (class IA) for all adults 21 years or older with an LDL cholesterol of 190 mg/dL or greater," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

Osimertinib Tops Standard EGFR-TKI for EGFR NSCLC

Osimertinib Tops Standard EGFR-TKI for <i>EGFR</i>&#43; NSCLC

Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC

Distinct Features for Drug Use-Related Endophthalmitis

Distinct Features for Drug Use-Related Endophthalmitis

Injection drug users have fewer comorbidities and more improvement in visual acuity after intervention

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Dating Violence Victimization, Nonmedical Rx Med Use Linked

Nonmedical use of prescription drugs linked to dating violence for male, female high school students

is free, fast, and customized just for you!

Already a member?

Sign In Now »